Bausch & Lomb Buys Eyeonics, Enters Premium IOL Market With Crystalens

Bausch & Lomb will enter the fast-growing premium intraocular lens market for the first time through its acquisition of Crystalens maker Eyeonics under a pact announced Jan. 20

More from Archive

More from Medtech Insight